{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:29:40Z","timestamp":1789997380012,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ahj.2014.09.012","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T11:47:49Z","timestamp":1411904869000},"page":"108-114.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cardiovascular prognosis in patients with type 2 diabetes: Contribution of heart and kidney subclinical damage"],"prefix":"10.1016","volume":"169","author":[{"given":"Philippe","family":"Sosner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Hulin-Delmotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Jean","family":"Saulnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verin","family":"Cabasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Gand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Torremocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Piguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Miot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Mar\u00e9chaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Herpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Ragot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2014.09.012_bb0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ahj.2014.09.012_bb0010","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00004872-200104000-00003","article-title":"Imaging techniques for non-invasive assessment of coronary heart disease in hypertension: value of an integrated approach","volume":"19","author":"de Simone","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2014.09.012_bb0015","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM199210013271406","article-title":"The heart in hypertension","volume":"327","author":"Frohlich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.09.012_bb0020","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/01.CIR.90.4.1786","article-title":"Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy","volume":"90","author":"Levy","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.09.012_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-71-1-89","article-title":"Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study","volume":"71","author":"Kannel","year":"1969","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2014.09.012_bb0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1067\/mhj.2001.113218","article-title":"Prognostic implications of left ventricular hypertrophy","volume":"141","author":"Vakili","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2014.09.012_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/jcp.43.1.3","article-title":"Increased albumin excretion in diabetes","volume":"43","author":"Townsend","year":"1990","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ahj.2014.09.012_bb0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/08860228509088195","article-title":"Microalbuminuria: an early marker of renal involvement in diabetes","volume":"9","author":"Mogensen","year":"1985","journal-title":"Uremia Invest"},{"key":"10.1016\/j.ahj.2014.09.012_bb0045","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.09.012_bb0050","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.09.012_bb0055","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2014.09.012_bb0060","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.09.012_bb0065","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.09.012_bb0070","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/cs1010671","article-title":"The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56)","volume":"101","author":"Stevens","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ahj.2014.09.012_bb0075","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.STR.0000020091.07144.C7","article-title":"UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine","volume":"33","author":"Kothari","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2014.09.012_bb0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/1741826710394270","article-title":"Contemporary model for cardiovascular risk prediction in people with type 2 diabetes","volume":"18","author":"Kengne","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.ahj.2014.09.012_bb0085","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2337\/dc07-2079","volume":"31","author":"Hadjadj","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2014.09.012_bb0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0002-8703(49)90562-1","article-title":"The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads","volume":"37","author":"Sokolow","year":"1949","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2014.09.012_bb0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archinte.1943.00210080052005","article-title":"Electrocardiographic criteria of left ventricular hypertrophy","volume":"72","author":"Gubner","year":"1943","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2014.09.012_bb0100","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/0735-1097(92)90376-X","article-title":"Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product","volume":"20","author":"Molloy","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.09.012_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2014.09.012_bb0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diabet.2007.06.001","article-title":"Microalbuminuria and urinary albumin excretion: French clinical practice guidelines","volume":"33","author":"Halimi","year":"2007","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ahj.2014.09.012_bb0115","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1161\/hc4201.097189","article-title":"Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests","volume":"104","author":"Greenland","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.09.012_bb0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.ahj.2014.09.012_bb0125","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1464-5491.2004.01246.x","article-title":"Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in type 2 diabetes: the Casale Monferrato Study","volume":"21","author":"Bruno","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/j.ahj.2014.09.012_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1475-2840-5-23","article-title":"Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study","volume":"5","author":"Cea-Calvo","year":"2006","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ahj.2014.09.012_bb0135","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.HYP.36.5.766","article-title":"Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators","volume":"36","author":"Okin","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2014.09.012_bb0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2337\/diacare.19.1.43","article-title":"Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects","volume":"19","author":"Bruno","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2014.09.012_bb0145","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1365-2362.2012.02726.x","article-title":"Prevalence of abnormal urinary albumin excretion in a population-based study in Spain: results from the HERMEX Study","volume":"42","author":"Robles","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ahj.2014.09.012_bb0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.09.012_bb0155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0002-8703(86)90156-0","article-title":"A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction: the Framingham Study","volume":"111","author":"Kannel","year":"1986","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2014.09.012_bb0160","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/HYPERTENSIONAHA.108.118026","article-title":"Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population","volume":"53","author":"Ishikawa","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2014.09.012_bb0165","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2014.09.012_bb0170","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1681\/ASN.2008121270","article-title":"Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes","volume":"20","author":"Ninomiya","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2014.09.012_bb0175","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.09.012_bb0180","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/01.CIR.87.4.1328","article-title":"Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts","volume":"87","author":"Schunkert","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.09.012_bb0185","first-page":"219","article-title":"Albuminuria reflects widespread vascular damage","volume":"32","author":"Deckert","year":"1989","journal-title":"Steno Hypotheses Diabetol"},{"key":"10.1016\/j.ahj.2014.09.012_bb0190","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1681\/ASN.2006050517","article-title":"Microalbuminuria as an early marker for cardiovascular disease","volume":"17","author":"de Zeeuw","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2014.09.012_bb0195","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/01.HYP.0000236599.91051.1e","article-title":"Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension","volume":"48","author":"Leoncini","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2014.09.012_bb0200","first-page":"204","article-title":"Urinary albumin excretion associated with arterial wall stiffness rather than thickness in type 2 diabetic patients","volume":"20","author":"Ishimura","year":"2007","journal-title":"J Nephrol"},{"key":"10.1016\/j.ahj.2014.09.012_bb0205","first-page":"36","article-title":"Normal and abnormal day-to-day variability of urinary albumin excretion in control and diabetic subjects","volume":"26","author":"Chau","year":"2000","journal-title":"Diabetes Metab"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870314006012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870314006012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:52:44Z","timestamp":1757569964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870314006012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0002870314006012"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2014.09.012","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular prognosis in patients with type 2 diabetes: Contribution of heart and kidney subclinical damage","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2014.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}